Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Change in Cash (2017 - 2026)

enVVeno Medical has reported Change in Cash over the past 4 years, most recently at $3.7 million for Q4 2020.

  • For Q4 2020, Change in Cash rose 326.48% year-over-year to $3.7 million; the TTM value through Dec 2020 reached $7.2 million, up 1257.81%, while the annual FY2025 figure was $1.3 million, 170.26% up from the prior year.
  • Change in Cash for Q4 2020 was $3.7 million at enVVeno Medical, up from $3.3 million in the prior quarter.
  • Over five years, Change in Cash peaked at $5.6 million in Q2 2018 and troughed at -$1.8 million in Q3 2018.
  • A 4-year average of $665619.1 and a median of $263504.0 in 2017 define the central range for Change in Cash.
  • Biggest five-year swings in Change in Cash: crashed 693.09% in 2018 and later skyrocketed 326.48% in 2020.
  • Year by year, Change in Cash stood at -$233795.0 in 2017, then crashed by 519.69% to -$1.4 million in 2018, then dropped by 12.93% to -$1.6 million in 2019, then skyrocketed by 326.48% to $3.7 million in 2020.
  • Business Quant data shows Change in Cash for NVNO at $3.7 million in Q4 2020, $3.3 million in Q3 2020, and $843795.0 in Q2 2020.